(a) A schematic diagram showing the behavior of the PTD-ODD-Luciferase-NIRF dye (POL-N) imaging probe in cells with (+) or without (?) HIF activity. CTZ, luciferase substrate coelenterazine. (b) ...

Tumor detection using targeted fluorescent imaging probes is a promising technology that takes advantage of specific molecular events occurring in cancer tissues. However, currently available probes ...

MINNEAPOLIS--(BUSINESS WIRE)--Vergent Bioscience, a clinical-stage biotechnology company developing tumor targeted imaging agents, announced new data being presented at the 2025 American Society of ...

Scientists used positron emission tomography (PET) with edaravone, a drug used to treat ALS, to detect oxidative stress, which leads to brain damage, offering a clear path to detecting neurological ...

Microendoscopes are the cornerstone of modern medical diagnostics - they allow us to see what we could not even describe two decades ago. The technology is constantly improving, with ICTER scientists ...

Leadoptik, a Silicon Valley startup company working to develop an optical probe for early-stage diagnosis of lung cancer, says it has raised $5 million in a round of seed funding. The San Jose firm ...

Widespread neurological conditions, including Alzheimer’s disease, Parkinson’s disease, epilepsy, multiple sclerosis, stroke, and brain tumors, are among the top causes of disability and death around ...

Investigators have developed and tested a targeted contrast agent that can detect blood clots in the hearts of patients with atrial fibrillation, or an irregular heartbeat. The strategy could be used ...

Molecular imaging is broadly defined by the Society of Nuclear Medicine as “the visualization, characterization, and measurement of biological processes at the molecular and cellular levels in humans ...

Microendoscopes using fiber optics are becoming increasingly important imaging tools, but they have physical limitations. They are essential for applications that require a long working distance, high ...